ABBV vs ANGO · P/E 81, rev $61.16B vs rev $292.5M
AbbVie Inc (ABBV) versus AngioDynamics Inc (ANGO) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. ANGO currently screens at market cap $378.5M.
Not investment advice. Open the ABBV and ANGO stock pages for the full models.
Not investment advice.